Vaccination

The LINK-VACC project links selected variables from existing registries for COVID-19 vaccine surveillance, in order to ensure the monitoring of COVID- 19 vaccines in the phase following their marketing authorization (post-authorization surveillance). This includes the measurement of uptake and coverage of the vaccination, the estimation of vaccine effectiveness, and continuous monitoring of the vaccine’s safety.

A collection of data (lab analysis and surveys) from a Belgian cohort of healthy people working at five sites across Belgium of the ‘External Department of Prevention and Protection at work’ of Mensura and at Carglass company. Data are about participants' immunity previous and after COVID-19 vaccination (dose 3) using mRNA COVID-19 vaccine BTB162b2. Redu-VAC is a randomised, multicenter, non-inferiority study investigating safety, reactogenicity and immunogenicity of a fractional booster dose (10µg versus 30µg) of the vaccine. Adverse events linked to the vaccination are available.

A collection of data (lab analysis and surveys) from a Belgian cohort of healthy and vulnerable population (elderly people, lung transplant recipients, kidney transplant recipients, immunodialyzed) people. Data are coming from a following of the participants' immunological response to COVID-19 analyzed 3 times a year (February, June, October). Participants' survey with their health status is also available.

This dataset contains information on fatalities attributed to COVID-19 in Belgium. The data is structured to provide details on a weekly basis, specifying the age of the deceased individuals, their region of residence within Belgium, and the classification of their COVID-19 cases (e.g., confirmed, probable).

This dataset provides information about the number of fatalities attributed to COVID-19 in Belgium. The data is likely organised based on the date of death, geographical region within Belgium, specific age groups, and the gender of the deceased individuals.

This dataset contains information about fatalities attributed to COVID-19 in Belgium. The data is structured to provide details on a weekly basis, specifying the age of the deceased individuals, their region of residence within Belgium, and the place where they died (e.g., hospitals, long-term care facilities, private residences).

This dataset contains information about fatalities attributed to COVID-19 in Belgium. The data is organised on a weekly basis and provides details on the age of the deceased individuals, the region in which they died, and the region where they were residents.

This dataset contains information on fatalities attributed to COVID-19 in Belgium. The data is organised on a weekly basis, providing details on the age of the deceased individuals, their region of residence within Belgium, and the type of residence they were living in.

Ce jeu de données contient des informations sur les efforts de vaccination contre le COVID-19 en Belgique. Les données sont organisées par la date de vaccination et comprennent des détails tels que la région où la vaccination a eu lieu, l'âge et le sexe des personnes recevant le vaccin, la marque spécifique du vaccin administré, et le numéro de la dose (première ou deuxième dose).

This dataset contains information on the impact of COVID-19 specifically on residents of nursing homes in Belgium. The data is organised by week, providing details on the number of confirmed COVID-19 case, hospitalisation, and death rates among nursing home residents. Additionally, the dataset distinguishes these figures based on different regions within Belgium.